UFP Technologies

UFPT

Market cap $1.67B

UFP Technologies, Inc. (UFPT) Q1 2026 Earnings Call Transcript

UFP Technologies (UFPT) came out with quarterly earnings of $2.48 per share, beating the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $2.47 per share a year ago.

NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.5 million for its first quarter ended March 31, 2026, 1.8% higher than net income of $17.2 million for the first quarter of 2025. Net sales for the quarter ended March 31, 2026 were $154.2 million, 4.1% higher than 2025 first quarter sales of $148.1 million. GAAP and a.

NEWBURYPORT, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that the Company plans to report results for the first quarter on Monday, May 4th, after the close of the stock market.

NEWBURYPORT, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming Raymond James 47th Annual Institutional Investors Conference to be held in Orlando, Florida March 1-4, 2026. UFP's presentation is scheduled to begin at 2:50 PM on Tuesday, March 3rd. A live webcast of UFP's presentation will be available here.

UFP Technologies, Inc. (UFPT) Q4 2025 Earnings Call Transcript

UFP Technologies (UFPT) came out with quarterly earnings of $2.44 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.46 per share a year ago.

NEWBURYPORT, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported 2025 net income of $68.3 million, 15.8% higher than net income of $59.0 million for 2024. Adjusted net income grew 12.7% to $76.1 million. Net sales for the year ended December 31, 2025 were $602.8 million, 19.5% higher than 2024 sales of $504.4 million. GAAP and adjusted earnings per diluted common share outstanding (“EPS”) for the year ended December 31, 2025 were $8.75 and $9.76, respectively.

NEWBURYPORT, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that the Company plans to report results for the fourth quarter and year-end on Tuesday, February 24th, after the close of the stock market.

This medtech stock has already been a 12-bagger over the past decade. It has built a leading position in its niche, helped in part by tuck-in acquisitions.